Skip to content Skip to left sidebar Skip to footer

Novavax COVID-19 Vaccine Now Expired!

Novavax COVID-19 Vaccine Now Expired!

Read on for more upcoming changes in COVID-19 product availability.

As of Friday, May 31, 2024 all doses of Novavax COVID-19 vaccine have expired. 

  • Remove any remaining doses from your storage units at this time.
  • Use this guide to waste any opened vaccine. 
  • Use this guide to return unopened vaccine.

See below for details on the availability of different products. If your preferred product is no longer available, change to an alternate product and continue to offer and administer COVID-19 vaccine to patients. 

Dosing Schedule: 2023-2024 COVID-19 Vaccine

For more details, review the CDC’s Interim 2023-2024 COVID-19 Immunization Schedule for Persons 6 Months of Age and Older.

Available Products (updated 6/3/2024): 2023-2024 COVID-19 Vaccine

Upcoming Changes in COVID-19 Vaccine Product Availability

CDC anticipates upcoming changes in the availability of COVID-19 vaccine products.

Here’s what we know now about the upcoming changes in product availability:

  • The latest expiration dates of the 2023-24 COVID-19 season NovaVax and Pfizer products are:
    • Novavax: 5/31/2024
    • Pfizer (6 mo – 4 yrs):  7/31/2024
    • Pfizer (5 yrs – 11 yrs and 12+): 8/31/2024
  • Moderna (6 mo – 11 yrs and 12+) products have expiration dates through late September

Be sure to check expiration dates before administering any vaccine.  

Other Considerations for COVID-19 Vaccine Product Expiration

  • The expiration dates indicated above are the latest 2023-2024 expiry. Your office may have vaccine products that expire sooner.
  • The beyond use date (BUD) supersedes the manufacturer’s expiration date. 

We will send additional messages to remind you about these expiration dates as they occur, provide guidance for inventory management, and inform you of other product updates as we are notified. 

If you have questions about COVID-19 vaccine availability, please reach out.

For VFC, email Victor Obeck at

For the Bridge Access Program, email Nyandra McFadden at